Nigel,
Thanks for the heads up on BDAL. They beat estimates for the quarter and year by a penny. A substantial amount in percentage terms. This gives them an enviable growth rate, as well. They also raised guidance by a penny. Even so, the teens seem fair versus the broad spectrum of companies -- i.e. the S&P -- considering we're talking about 7 cents here. I don't see much downside for BDAL, though I don't see it being an one year five-bagger, either. Happy to have it in Trickle for what has been paid.
I am a little shell-shocked with ABSC, and I've definitely been tempted. Mike's advice to wait was sound, but I don't see much downside for it, either, and it sure wouldn't cost much to nibble at these prices, would it? But given their guidance, I don't think ABSC is going to rise quickly. I think I may yet get WAT below $60, and ABI at $65. SIAL seems destined to slowly grind upward without me. Meanwhile watching MCLS and DPII. Also wondering if I might get INCY below $15. I'd like to have 10 grand or so of dry powder even after those (or similar) buys. Who knows, maybe I can get XGEN and APBI for $5 and $7 if they dare to show their faces this year.
I think I have a little more time to dither about what to buy. Dithering often helps keep me from buying too early. It is still my feeling that a climax sell-off is in the offing. Margin calls, and the fact that rate cuts are going to take a while to have an effect. What got me cautious was ABSC's guidance and TECH's miss. Though not getting fundamentally hurt as badly as semiconductor companies, the trickle companies hadn't been beaten up so badly beforehand, either, so had some room to fall. I figure on waiting for this warning season to pass in most cases. ABSC does seem compelling now, I must say.
In real life, sold some PRCS puts today.
Cheers, Tuck |
